New York, New York--(Newsfile Corp. - June 26, 2024) - Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, is investigating whether certain directors and officers of Ventyx Biosciences, Inc. ("Ventyx") (NASDAQ: VTYX) breached their fiduciary duties to Ventyx and its shareholders. If you are a Ventyx shareholder, you are encouraged to contact attorney Joe Pettigrew with Scott+Scott for additional information at (844) 818-6982 or jpettigrew@scott-scott.com.
Scott+Scott is investigating whether members of Ventyx's board of directors or senior management failed to manage Ventyx in an acceptable manner, in breach of their fiduciary duties to Ventyx, and whether Ventyx and its shareholders have suffered damages as a result.
As confirmed by filings with the Securities and Exchange Commission, Ventyx directors and officers collectively sold nearly $90 million in stock before disclosing poor clinical trial results, which caused dramatic declines in Ventyx's stock price. Many of these sales are suspicious in timing and amount.
What You Can Do
If you are a Ventyx shareholder, you may have legal claims against Ventyx's directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at (844) 818-6982 or jpettigrew@scott-scott.com.
About Scott+Scott Attorneys at Law LLP
Scott+Scott has significant experience in prosecuting major securities, antitrust, and consumer rights actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, California, and Ohio.
Attorney Advertising
CONTACT:
Joe Pettigrew
Scott+Scott Attorneys at Law LLP
230 Park Avenue, 17th Floor, New York, NY 10169
(844) 818-6982
jpettigrew@scott-scott.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/212395
